Skip to content
Inciteful Med

Understanding a Congenital Hyperinsulinism Diagnosis: A Guide for Families

Last updated:

Congenital Hyperinsulinism (CHI) is a rare genetic condition where a child's pancreas produces too much insulin, causing severe low blood sugar. With prompt treatment using medications or surgery, serious complications are preventable. Care at a specialized CHI center is highly recommended.

Key Takeaways

  • • Congenital hyperinsulinism is a genetic condition and is never caused by a parent's actions or choices during pregnancy.
  • • Consistent monitoring and proactive medical treatment can prevent the brain damage associated with severe low blood sugar.
  • • Effective treatments exist for CHI, including medications like diazoxide and octreotide, and sometimes curative surgery.
  • • Early evaluation at a specialized CHI Center of Excellence provides critical access to rapid genetic testing and advanced imaging.

Receiving a diagnosis of Congenital Hyperinsulinism (CHI) can feel overwhelming and frightening. It is a rare condition, affecting approximately 1 in 25,000 to 1 in 50,000 live births [1][2]. While the news is difficult, it is important to know that you are not alone, and with the right specialized care, children with CHI can lead full, healthy lives.

What is CHI?

In a healthy body, the pancreas releases a hormone called insulin to help cells use sugar (glucose) for energy. When blood sugar drops, the pancreas stops releasing insulin. In a child with CHI, the “off switch” for insulin does not work correctly. The pancreas continues to pump out insulin even when blood sugar is dangerously low [3][4]. The medical team will usually set a target “safe” blood sugar level (typically >70 mg/dL, though this can vary) that you will aim to maintain to protect your child [5].

This is different from transient neonatal hypoglycemia, which is a temporary dip in blood sugar often seen in infants of diabetic mothers or babies born small for their gestational age. While transient hypoglycemia usually resolves within a few days, CHI is a persistent condition caused by genetic changes that require specialized medical management [3][6].

It Is Not Your Fault

One of the first things many parents feel is a sense of guilt. It is vital to understand that CHI is a genetic condition [7]. It is not caused by anything you did or did not do during pregnancy. It is not related to your diet, your exercise habits, or your stress levels while you were expecting [8][4]. These genetic changes can be inherited from one or both parents, or they can occur spontaneously (called a de novo mutation) for the first time in your child [9][10].

Three Stabilizing Facts

When the world feels uncertain, focus on these three truths about CHI:

  1. Brain Damage is Preventable: While low blood sugar (hypoglycemia) is serious, consistent monitoring and proactive treatment can prevent the long-term neurological issues sometimes associated with the condition [11][12].
  2. Effective Treatments Exist: There are several ways to manage CHI, including medications like diazoxide (which helps “open” the channels that control insulin) and octreotide (which tells the pancreas to stop releasing insulin) [5][13]. For some children with a specific “focal” form of the disease, surgery can even be curative [5][14].
  3. You Will Become an Expert: Right now, the monitors and medical terms feel like a foreign language. In time, you will understand your child’s unique patterns, and you will have a care team to support you every step of the way [5][11].

The Importance of Specialized Care

Because CHI is so rare, many local pediatricians and even general endocrinologists may only see one case in their entire career [15]. This is why it is critical for your child to be evaluated at a Specialized CHI Center of Excellence.

Specialized centers offer access to:

  • Rapid Genetic Testing: Identifying the specific gene involved (such as ABCC8 or KCNJ11) helps doctors choose the most effective treatment [16][10].
  • Advanced Imaging: Specialized scans (like 18F-DOPA PET/CT) can help surgeons locate “focal” areas of the pancreas that might be safely removed [5][4].
  • Multidisciplinary Teams: Experts in pediatric endocrinology, surgery, genetics, and nutrition work together to create a personalized plan for your child [5][17].

Early diagnosis and treatment at a specialized center significantly improve long-term outcomes for children with CHI [12][11].

Frequently Asked Questions

What is congenital hyperinsulinism (CHI)?
CHI is a rare genetic condition where a baby's pancreas produces too much insulin even when blood sugar is low. This causes dangerous drops in blood sugar that require specialized medical treatment to prevent complications like brain damage.
Did I do something during pregnancy to cause my baby's CHI?
No, CHI is a genetic condition and is not caused by anything a mother did or did not do during pregnancy. It is completely unrelated to your diet, exercise, or stress levels while you were expecting.
What is the difference between CHI and transient neonatal hypoglycemia?
Transient neonatal hypoglycemia is a temporary drop in blood sugar that usually resolves within a few days of birth. In contrast, CHI is a persistent, lifelong condition caused by genetic changes that require ongoing specialized medical management.
How is congenital hyperinsulinism treated?
Treatment often involves medications like diazoxide or octreotide to reduce insulin production and stabilize blood sugar. In certain focal cases of CHI, specialized surgery to remove a specific part of the pancreas can cure the condition.
Why does my child need to be seen at a specialized CHI center?
Because CHI is very rare, local hospitals may lack the specific experience needed for optimal care. Specialized centers offer multidisciplinary teams, rapid genetic testing, and advanced imaging to safely tailor the best treatment plan for your child.

Questions for Your Doctor

  • • Based on the glucose infusion rate (GIR), how severe is my child's hyperinsulinism?
  • • Do you suspect my child has a focal, diffuse, or transient form of CHI, and how will we confirm this?
  • • Can we initiate rapid genetic testing immediately to determine which specific gene is affected?
  • • How many patients with CHI does this hospital treat each year, and are you in contact with a specialized CHI Center of Excellence?
  • • What is our immediate plan for preventing brain injury during blood sugar lows while we are still in the hospital?
  • • What is the target "safe" blood sugar level we will be aiming for during stabilization and when we go home?
  • • What are the potential side effects of the medications being considered for my child?

Questions for You

  • • What were the first signs or symptoms I noticed in my child before the diagnosis?
  • • Is there any history of "sugar issues," neonatal seizures, or early-onset diabetes on either side of our family?
  • • How am I feeling emotionally, and what support (family, friends, or professional) do I need to manage this stress?
  • • What are my biggest fears about managing my child's blood sugar at home, and who can help me practice using the monitoring equipment?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Tracer Accumulation in Relation to Venous Thrombus on 18F-DOPA PET/CT in a Case of Persistent Hyperinsulinemic Hypoglycemia of Infancy.

    Arora S, Damle NA, Passah A, et al.

    Nuclear medicine and molecular imaging 2019; (53(2)):148-151 doi:10.1007/s13139-018-00568-5.

    PMID: 31057687
  2. 2

    Using referral rates for genetic testing to determine the incidence of a rare disease: The minimal incidence of congenital hyperinsulinism in the UK is 1 in 28,389.

    Yau D, Laver TW, Dastamani A, et al.

    PloS one 2020; (15(2)):e0228417 doi:10.1371/journal.pone.0228417.

    PMID: 32027664
  3. 3

    Challenging diagnosis of congenital hyperinsulinism in two infants of diabetic mothers with rare pathogenic KCNJ11 and HNF4A gene variants.

    Huerta-Saenz L, Saunders C, Yan Y

    International journal of pediatric endocrinology 2018; (2018()):5 doi:10.1186/s13633-018-0060-7.

    PMID: 30026763
  4. 4

    Early diagnosis of focal congenital hyperinsulinism: A fluorine-18-labeled l-dihydroxyphenylalanine positron emission tomography/computed tomography study.

    Burroni L, Palucci A, Biscontini G, Cherubini V

    World journal of nuclear medicine 2021; (20(4)):395-397 doi:10.4103/wjnm.wjnm_159_20.

    PMID: 35018160
  5. 5

    Congenital hyperinsulinism: localization of a focal lesion with 18F-FDOPA positron emission tomography.

    States LJ, Becker SA, De León DD

    Pediatric radiology 2022; (52(4)):693-701 doi:10.1007/s00247-021-05206-5.

    PMID: 34668049
  6. 6

    New approaches to screening and management of neonatal hypoglycemia based on improved understanding of the molecular mechanism of hypoglycemia.

    Stanley CA, Thornton PS, De Leon DD

    Frontiers in pediatrics 2023; (11()):1071206 doi:10.3389/fped.2023.1071206.

    PMID: 36969273
  7. 7

    Syndromic forms of congenital hyperinsulinism.

    Zenker M, Mohnike K, Palm K

    Frontiers in endocrinology 2023; (14()):1013874 doi:10.3389/fendo.2023.1013874.

    PMID: 37065762
  8. 8

    Congenital Hyperinsulinism.

    Sims K

    NeoReviews 2021; (22(4)):e230-e240 doi:10.1542/neo.22-4-e230.

    PMID: 33795398
  9. 9

    Pulmonary hypertension occurring with diazoxide use in a preterm infant with hypoglycemia.

    Kylat RI

    Drug, healthcare and patient safety 2019; (11()):7-10 doi:10.2147/DHPS.S198255.

    PMID: 30881142
  10. 10

    A Novel HNF4A Mutation Causing Three Phenotypic Forms of Glucose Dysregulation in a Family.

    Chandran S, Rajadurai VS, Hoi WH, et al.

    Frontiers in pediatrics 2020; (8()):320 doi:10.3389/fped.2020.00320.

    PMID: 32670997
  11. 11

    Congenital hyperinsulinism in clinical practice: From biochemical pathophysiology to new monitoring techniques.

    Martino M, Sartorelli J, Gragnaniello V, Burlina A

    Frontiers in pediatrics 2022; (10()):901338 doi:10.3389/fped.2022.901338.

    PMID: 36210928
  12. 12

    [Congenital hyperinsulinism: Loss of B-cell self-control].

    Lebl J, Roženková K, Průhová Š

    Vnitrni lekarstvi 2016; (62(11 Suppl 4)):S72-76.

    PMID: 27921429
  13. 13

    Persistent hyperinsulinemic hypoglycemia of infancy: a clinical and pathological study of 19 cases in a single institution.

    Li J, Ma Y, Lv M, et al.

    International journal of clinical and experimental pathology 2015; (8(11)):14417-24.

    PMID: 26823758
  14. 14

    Pathological features in non-neoplastic congenital and adult hyperinsulinism: from nesidioblastosis to current terminology and understanding.

    Sempoux C, Klöppel G

    Endocrine-related cancer 2023; (30(9)).

    PMID: 37279235
  15. 15

    Nationwide survey of endogenous hyperinsulinemic hypoglycemia in Japan (2017-2018): Congenital hyperinsulinism, insulinoma, non-insulinoma pancreatogenous hypoglycemia syndrome and insulin autoimmune syndrome (Hirata's disease).

    Yamada Y, Kitayama K, Oyachi M, et al.

    Journal of diabetes investigation 2020; (11(3)):554-563 doi:10.1111/jdi.13180.

    PMID: 31742894
  16. 16

    Detection of hepatocyte nuclear factor 4A(HNF4A) gene variant as the cause for congenital hyperinsulinism leads to revision of the diagnosis of the mother.

    Vlachopapadopoulou EA, Dikaiakou E, Fotiadou A, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2021; (34(4)):527-530 doi:10.1515/jpem-2020-0302.

    PMID: 33031054
  17. 17

    Carbamazepine promotes surface expression of mutant Kir6.2-A28V ATP-sensitive potassium channels by modulating Golgi retention and autophagy.

    Lin CH, Lin YC, Yang SB, Chen PC

    The Journal of biological chemistry 2022; (298(5)):101904 doi:10.1016/j.jbc.2022.101904.

    PMID: 35398096

This guide is for educational purposes to help families understand a Congenital Hyperinsulinism diagnosis. Always consult a pediatric endocrinologist or CHI specialist for your child's medical care and treatment plan.

Stay up to date

Get notified when new research about Congenital isolated hyperinsulinism is published.

No spam. Unsubscribe anytime.